Skip to main content
. 2018 Jun 11;9(2):169–174. doi: 10.3892/br.2018.1111

Table I.

Baseline characteristics of enrolled patients in each first-line treatment group.

Variable VPZ/AMPC/CAM LPZ/AMPC/CAM P-value
n 275 249
Age, years, median (range) 62.7 (27–92) 61.9 (26–88) 0.572
Sex, male:female, n 154:121 143:106 0.742

VPZ, vonoprazan; AMPC, amoxicillin; CAM, clarithromycin; LPZ, lansoprazole.